Home NDC 42291-487 Potassium Chloride
Product NDC 42291-487
11-digit product format 422910487
Labeler code 42291
Product ID 42291-487_3bdfceef-6db4-8d5d-e063-6294a90abecc
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Potassium Chloride
Dosage form TABLET, EXTENDED RELEASE
Route ORAL
Labeler AvKARE
Application ANDA218979
Marketing category ANDA
Marketing start 2025-08-08
Substance POTASSIUM CHLORIDE
Active strength 750 mg/1
Pharmacologic classes Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A218979-001 KLOR-CON POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 A218979-002 KLOR-CON POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A218979-001 KLOR-CON 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 c2088c7a36db…2026-10-15 13:18:30 2026-09 A218979-002 KLOR-CON 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 c2088c7a36db…2026-09-14 22:38:34 2026-08 A218979-001 KLOR-CON 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 A218979-002 KLOR-CON 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 84e616aacf4f…2026-08-18 06:07:40 2026-07 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 2680178bc6a6…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 d8e5a09893c0…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A218979-001 POTASSIUM CHLORIDE 8MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A218979-002 POTASSIUM CHLORIDE 10MEQ TABLET, EXTENDED RELEASE / ORAL AB2 2024-10-28 a50c72e98297…
Observed Orange Book normalized TE history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Potassium Chloride
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength POTASSIUM CHLORIDE 750 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 660YQ98I10 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 628953 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 42291-487-01 Potassium Chloride 100 in 1 BOTTLE TABLET, EXTENDED RELEASE 100 1 42291-487-50 Potassium Chloride 500 in 1 BOTTLE TABLET, EXTENDED RELEASE 500 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 42291-487-01 42291048701 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-487-01) 2025-08-08 No No Current 42291-487-50 42291048750 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-487-50) 2025-08-08 No No Current